VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |